Hui Zhang

Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia

Benshang Li, Samuel W. Brady, Xiaotu Ma et al. · Blood · 2019 · 286 citations · Full text

West Nile Virus Infection in the Golden Hamster (<i>Mesocricetus auratus</i>): A Model for West Nile Encephalitis

Shu-Yuan Xiao, Hilda Guzmán, Hui Zhang et al. · Emerging infectious diseases · 2001 · 250 citations · Full text

Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

Shuhong Shen, Xiaojuan Chen, Jiaoyang Cai et al. · JAMA Oncology · 2020 · 231 citations · Full text

Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial

Michael Wang, Hun Ju Lee, Hubert H. Chuang et al. · The Lancet Oncology · 2015 · 212 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +6

Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study

Hagop M. Kantarjian, Daniel J. DeAngelo, Anjali S. Advani et al. · The Lancet Haematology · 2017 · 209 citations

Inotuzumab Ozogamicin, Hematological Malignancy, Oncology +9